Arch Biopartners Receives Health Canada Authorization to Amend Phase II Trial Protocol for LSALT Peptide

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement